149 related articles for article (PubMed ID: 33323531)
1. Improving Pneumococcal Vaccination Rates in Rheumatology Patients by Using Best Practice Alerts in the Electronic Health Records.
Sheth HS; Grimes VD; Rudge D; Ayers B; Moreland LW; Fischer GS; Aggarwal R
J Rheumatol; 2021 Sep; 48(9):1472-1479. PubMed ID: 33323531
[TBL] [Abstract][Full Text] [Related]
2. Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project.
Sheth H; Moreland L; Peterson H; Aggarwal R
J Rheumatol; 2017 Jan; 44(1):11-17. PubMed ID: 28042124
[TBL] [Abstract][Full Text] [Related]
3. Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert.
Ledwich LJ; Harrington TM; Ayoub WT; Sartorius JA; Newman ED
Arthritis Rheum; 2009 Nov; 61(11):1505-10. PubMed ID: 19877088
[TBL] [Abstract][Full Text] [Related]
4. Implementing a Nurse-Driven Protocol for Pneumococcal Vaccination in an Academic Rheumatology Clinic.
Joerns EK; Pokala N; Bermas B; Reisch J; Wang DC; Arasaratnam R; Bajaj P
J Rheumatol; 2023 Mar; 50(3):413-419. PubMed ID: 36319017
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital.
Smith JG; Metzger NL
J Manag Care Pharm; 2011 Nov; 17(9):701-8. PubMed ID: 22050395
[TBL] [Abstract][Full Text] [Related]
6. A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center.
Burns CM; Banks RE; Wilson BM; Carter RR; Jump RLP; Perez F
AIDS Care; 2018 Feb; 30(2):146-149. PubMed ID: 29052434
[TBL] [Abstract][Full Text] [Related]
7. Previsit Planning Improves Pneumococcal Vaccination Rates in Childhood-Onset SLE.
Sivaraman V; Wise KA; Cotton W; Barbar-Smiley F; AlAhmed O; MacDonald D; Lemle S; Yildirim-Toruner C; Ardoin SP; Ardura MI
Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31879277
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years.
Black CL; Williams WW; Warnock R; Pilishvili T; Kim D; Kelman JA
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(27):728-733. PubMed ID: 28704347
[TBL] [Abstract][Full Text] [Related]
9. Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting.
McAdam-Marx C; Tak C; Petigara T; Jones NW; Yoo M; Briley MS; Gunning K; Gren L
BMC Health Serv Res; 2019 Jul; 19(1):474. PubMed ID: 31291959
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.
Svensson T; Kättström M; Hammarlund Y; Roth D; Andersson PO; Svensson M; Nilsson I; Rombo L; Cherif H; Kimby E
Vaccine; 2018 Jun; 36(25):3701-3707. PubMed ID: 29748028
[TBL] [Abstract][Full Text] [Related]
11. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.
Jackson LA; Gurtman A; van Cleeff M; Frenck RW; Treanor J; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2013 Aug; 31(35):3594-602. PubMed ID: 23688525
[TBL] [Abstract][Full Text] [Related]
12. Influenza, PCV13, and PPSV23 Vaccination Rates Among Inflammatory Bowel Disease Patients With Additional Co-Morbidities as per CDC Recommendations.
Jordan A; Mills K; Sobukonla T; Kelly A; Flood M
Cureus; 2021 Sep; 13(9):e18387. PubMed ID: 34729268
[TBL] [Abstract][Full Text] [Related]
13. A quality improvement intervention failed to significantly increase pneumococcal and influenza vaccination rates in immunosuppressed inflammatory arthritis patients.
Murray K; Low C; O'Rourke A; Young F; Callanan I; Feeney E; Veale DJ
Clin Rheumatol; 2020 Mar; 39(3):747-754. PubMed ID: 31820135
[TBL] [Abstract][Full Text] [Related]
14. A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination.
Cannon K; Elder C; Young M; Scott DA; Scully IL; Baugher G; Peng Y; Jansen KU; Gruber WC; Watson W
Vaccine; 2021 Dec; 39(51):7494-7502. PubMed ID: 34839993
[TBL] [Abstract][Full Text] [Related]
15. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.
Greenberg RN; Gurtman A; Frenck RW; Strout C; Jansen KU; Trammel J; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2014 Apr; 32(20):2364-74. PubMed ID: 24606865
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine.
Smith KJ; Wateska AR; Nowalk MP; Raymund M; Nuorti JP; Zimmerman RK
JAMA; 2012 Feb; 307(8):804-12. PubMed ID: 22357831
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.
Tromp KM; Campbell MW; Vazquez A
Clin Ther; 2015 May; 37(5):928-34. PubMed ID: 25913921
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pneumococcal and influenza vaccination coverage in rheumatology patients receiving biological therapy in a regional referral hospital.
Fernández-Prada M; Brandy-García AM; Rodríguez-Fonseca OD; Huerta-González I; Fernández-Noval F; Martínez-Ortega C
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):97-102. PubMed ID: 29752214
[TBL] [Abstract][Full Text] [Related]
19. A Nationwide Digital Multidisciplinary Intervention Aimed at Promoting Pneumococcal Vaccination in Immunocompromised Patients.
Shapiro Ben David S; Shamai-Lubovitz O; Mourad V; Goren I; Cohen Iunger E; Alcalay T; Irony A; Greenfeld S; Adler L; Cahan A
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631923
[TBL] [Abstract][Full Text] [Related]
20. Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults.
Schmoele-Thoma B; van Cleeff M; Greenberg RN; Gurtman A; Jones TR; Sundaraiyer V; Gruber WC; Scott DA
Hum Vaccin Immunother; 2019; 15(3):575-583. PubMed ID: 30648932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
